TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 11203813

Group type: EXPERIMENTAL
Intervention: Amalgambond Plus and Tytin amalgam (small restorations)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Tytin amalgam (small restorations)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Amalgambond Plus and Tytin amalgam (large restorations)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Tytin amalgam (large restorations)
Number of subjects: 60
Study: 9339929

Group type: EXPERIMENTAL
Intervention: Pulmonary artery catheter (PAC) placed preoperatively with hemodynamic optimization (Group I)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Standard care without routine PAC placement (Group II)
Number of subjects: 104
Study: 8095449

Group type: EXPERIMENTAL
Intervention: Inhalation of 1 mg of terbutaline (4 puffs)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 3953532

Group type: EXPERIMENTAL
Intervention: Tryptophan
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Phenylalanine
Number of subjects: 13

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 13
Study: 31628456

Group type: EXPERIMENTAL
Intervention: Limited future time perspective
Number of subjects: 438

Group type: EXPERIMENTAL
Intervention: Death reflection
Number of subjects: 438

Group type: COMPARATOR
Intervention: Mortality salience
Number of subjects: 438
Study: 30049669

Group type: EXPERIMENTAL
Intervention: Gamified intervention
Number of subjects: 94

Group type: COMPARATOR
Intervention: Nongamified intervention
Number of subjects: 94
Study: 26955982

Group type: EXPERIMENTAL
Intervention: Bifocal psychoeducation
Number of subjects: 41

Group type: COMPARATOR
Intervention: Standard treatment (TAU)
Number of subjects: 41
Study: 26220054

Group type: EXPERIMENTAL
Intervention: Dual plane flap inset
Number of subjects: 50

Group type: COMPARATOR
Intervention: Single plane flap inset
Number of subjects: 50
Study: 23055402

Group type: EXPERIMENTAL
Intervention: Acebutolol
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Diltiazem
Number of subjects: 117

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 117
Study: 20670761

Group type: EXPERIMENTAL
Intervention: Surgical ventricular reconstruction (SVR) added to CABG
Number of subjects: 2036

Group type: COMPARATOR
Intervention: CABG without SVR
Number of subjects: 2036

Group type: EXPERIMENTAL
Intervention: Cox proportional hazard ratios of 1,000 STICH patients in 3 RAR groups
Number of subjects: 2036
Study: 18484252

Group type: EXPERIMENTAL
Intervention: Extracorporal shock-wave therapy (ESWT)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Sham ESWT (placebo)
Number of subjects: 48
Study: 16839262

Group type: EXPERIMENTAL
Intervention: Bilateral greater occipital nerve (GON) block with 0.25% bupivacaine
Number of subjects: 82

Group type: COMPARATOR
Intervention: Control group (no prior block)
Number of subjects: 82
Study: 12777360

Group type: EXPERIMENTAL
Intervention: Sustained quitters (smoking cessation in the first year)
Number of subjects: 5346

Group type: EXPERIMENTAL
Intervention: Sustained quitters
Number of subjects: 5346

Group type: EXPERIMENTAL
Intervention: Methacholine reactivity
Number of subjects: 5346
Study: 10857365

Group type: EXPERIMENTAL
Intervention: Suntan parlor exposures (10 full-body UV exposures over a 2 week period, shielding only the right flexural arm)
Number of subjects: 22

Group type: COMPARATOR
Intervention: No exposure (control group)
Number of subjects: 22
Study: 9021700

Group type: EXPERIMENTAL
Intervention: Oral ciprofloxacin
Number of subjects: 10
Study: 8256187

Group type: EXPERIMENTAL
Intervention: Cefepime 2 grams every 12 hours IVPB plus metronidazole 0.5 grams every eight hours IVPB (C/M)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Gentamicin 1.5 milligrams per kilogram IVPB plus clindamycin 0.9 grams every eight hours IVPB (G/C)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Cefepime plus metronidazole (C/M)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Gentamicin plus clindamycin (G/C)
Number of subjects: 96
Study: 3155916

Group type: EXPERIMENTAL
Intervention: Group conference phone calls with self-determined task assignments for 8 weeks
Number of subjects: 38
Study: 29698112

Group type: EXPERIMENTAL
Intervention: 10-cm Visual Analog Scale (VAS)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: GOSLON Yardstick
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: 3D digital models
Number of subjects: 70

Group type: COMPARATOR
Intervention: Conventional plaster models
Number of subjects: 70
Study: 30065246

Group type: EXPERIMENTAL
Intervention: Family Check-Up (FCU)
Number of subjects: 231

Group type: COMPARATOR
Intervention: Internet-delivered Parent Training (iComet)
Number of subjects: 231
Study: 27325103

Group type: EXPERIMENTAL
Intervention: CO2 fractional laser photothermolysis followed by 4 weeks topical application of B‐Resorcinol and Glycyrrhetinic acid
Number of subjects: 11

Group type: COMPARATOR
Intervention: Topical application of B‐Resorcinol and Glycyrrhetinic acid only
Number of subjects: 11
Study: 25411293

Group type: EXPERIMENTAL
Intervention: Daily 500 μg vitamin B‐12 plus 400 μg folic acid supplementation for 2 years (including 600 IU vitamin D3)
Number of subjects: 2919

Group type: COMPARATOR
Intervention: Placebo supplementation for 2 years (including 600 IU vitamin D3)
Number of subjects: 2919

Group type: EXPERIMENTAL
Intervention: Daily 500 μg vitamin B‐12 plus 400 μg folic acid supplementation for 2 years
Number of subjects: 2919

Group type: COMPARATOR
Intervention: Placebo supplementation for 2 years
Number of subjects: 2919
Study: 23290324

Group type: EXPERIMENTAL
Intervention: Metadoxine ER 1,400 mg/d for 6 weeks
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Metadoxine ER
Number of subjects: 120
Study: 20231213

Group type: EXPERIMENTAL
Intervention: Pendulum appliance supported with a K-loop buccally (group 1)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Cervical headgear (CHG) (group 2)
Number of subjects: 30
Study: 18976162

Group type: EXPERIMENTAL
Intervention: Fentanyl 15 microg/kg + Ondansetron 12 mg
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Fentanyl 12.5 microg/kg + Ketorolac 1.5 mg/kg + Ondansetron 12 mg
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Fentanyl 10 microg/kg + Ketorolac 3 mg/kg + Ondansetron 12 mg
Number of subjects: 135
Study: 16096176

Group type: EXPERIMENTAL
Intervention: Gonadotropin releasing hormone (GnRH, goserelin 3.6 mg) administered subcutaneously every 28 days for 12 weeks
Number of subjects: 12
Study: 11835027

Group type: EXPERIMENTAL
Intervention: Intravenous testosterone (2 doses designed to increase testosterone 2 or 6 times baseline)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 11273540

Group type: EXPERIMENTAL
Intervention: Test brand (Panacea Biotec Ltd.)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Reference brand (Pfizer India Ltd.)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Both brands
Number of subjects: 12
Study: 9065542

Group type: EXPERIMENTAL
Intervention: Occupational exposure to copper for more than 20 years
Number of subjects: 608

Group type: EXPERIMENTAL
Intervention: Occupational exposure to manganese for more than 20 years
Number of subjects: 608

Group type: EXPERIMENTAL
Intervention: Combinations of lead-copper exposure for more than 20 years
Number of subjects: 608

Group type: EXPERIMENTAL
Intervention: Combinations of lead-iron exposure for more than 20 years
Number of subjects: 608

Group type: EXPERIMENTAL
Intervention: Combinations of iron-copper exposure for more than 20 years
Number of subjects: 608
Study: 8349063

Group type: EXPERIMENTAL
Intervention: Cervical brush
Number of subjects: 301

Group type: COMPARATOR
Intervention: Plastic spatula
Number of subjects: 301

Group type: COMPARATOR
Intervention: Cotton swab
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: All instruments
Number of subjects: 301
Study: 3034034

Group type: COMPARATOR
Intervention: Ramipril 5 mg (3 times at 12-hour intervals)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Ramipril 10 mg daily for 2 weeks
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 31195892

Group type: EXPERIMENTAL
Intervention: Monocular viewing
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Binocular viewing with monocular blur
Number of subjects: 23

Group type: COMPARATOR
Intervention: Binocular viewing
Number of subjects: 23
Study: 29326192

Group type: EXPERIMENTAL
Intervention: Cash transfers conditional on school attendance
Number of subjects: 3889
Study: 27391675

Group type: EXPERIMENTAL
Intervention: Behavioural Activation Treatment for Depression (Activate) - 10 individual 60-min therapy sessions with a psychologist, in addition to treatment as usual (TAU)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 200
Study: 24398888

Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 200

Group type: COMPARATOR
Intervention: Lisinopril
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Both
Number of subjects: 200
Study: 22438366

Group type: EXPERIMENTAL
Intervention: CT colonography
Number of subjects: 547

Group type: COMPARATOR
Intervention: Colonoscopy
Number of subjects: 547
Study: 20303597

Group type: EXPERIMENTAL
Intervention: Vibration-assisted anesthesia
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo (static vibration off)
Number of subjects: 80
Study: 18658066

Group type: EXPERIMENTAL
Intervention: Language-Focused Curriculum (LFC) implemented by treatment teachers for an academic year.
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Teacher use of language stimulation techniques (LSTs) such as open questions, recasts, models.
Number of subjects: 196

Group type: COMPARATOR
Intervention: Control group maintained their prevailing curriculum.
Number of subjects: 196
Study: 15919007

Group type: EXPERIMENTAL
Intervention: Tertiary care (Group A)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Primary care (Group B)
Number of subjects: 87
Study: 12888401

Group type: EXPERIMENTAL
Intervention: Video education (6 sessions)
Number of subjects: 197

Group type: COMPARATOR
Intervention: Oral presentation (8 sessions)
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 197
Study: 10573549

Group type: EXPERIMENTAL
Intervention: Atole (high energy, high protein supplement)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Fresco (low energy, no-protein supplement)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Completion of primary school
Number of subjects: 240
Study: 8767568

Group type: EXPERIMENTAL
Intervention: Preventive group (100 mg tramadol at extubation + continuous infusion of 200 mg tramadol)
Number of subjects: 94

Group type: COMPARATOR
Intervention: On-demand group (placebo at extubation + bolus tramadol on demand)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Preventive group
Number of subjects: 94

Group type: COMPARATOR
Intervention: On-demand group
Number of subjects: 94
Study: 1920782

Group type: EXPERIMENTAL
Intervention: Clonidine (5 micrograms.kg‐1)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (no clonidine)
Number of subjects: 30
Study: 31079083

Group type: EXPERIMENTAL
Intervention: Acupuncture with Doin therapy
Number of subjects: 124

Group type: COMPARATOR
Intervention: Acupuncture alone
Number of subjects: 124
Study: 28209560

Group type: EXPERIMENTAL
Intervention: Full ASPIRE program (experimental condition, n=50)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Online text-based version of ASPIRE (control condition, n=51)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Full ASPIRE program (experimental condition)
Number of subjects: 101
Study: 25590331

Group type: EXPERIMENTAL
Intervention: Public health intervention promoting expedited partner therapy (EPT) with free patient-delivered partner therapy (PDPT) available to clinicians.
Number of subjects: 23
Study: 23688367

Group type: EXPERIMENTAL
Intervention: Integrated Pain Management Program (IPMP) for staff and residents, consisting of 8 weeks of activities including gardening therapy and physiotherapy exercise.
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Integrated Pain Management Program (IPMP) for residents.
Number of subjects: 90
Study: 21298444

Group type: EXPERIMENTAL
Intervention: Bilateral hopping intervention (5-7 sets of 10 s timed bilateral hopping exercise at 75-90% intensity three times/week)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Bilateral hopping intervention
Number of subjects: 25
Study: 20027365

Group type: EXPERIMENTAL
Intervention: Tenoten and Tenoten (pediatric formulation)
Number of subjects: 0
Study: 17578751

Group type: EXPERIMENTAL
Intervention: Glucosamine (1500 mg per day)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 106
Study: 15539864

Group type: EXPERIMENTAL
Intervention: Amitriptyline
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Citalopram
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Combination of amitriptyline and citalopram
Number of subjects: 88
Study: 11314213

Group type: EXPERIMENTAL
Intervention: 3% benzalkonium chloride solution
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: 32% phosphoric acid with benzalkonium chloride
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: 35% phosphoric acid
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: 10% maleic acid
Number of subjects: 25
Study: 9503181

Group type: EXPERIMENTAL
Intervention: Aspirin plus ticlopidine (250 mg)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Aspirin (100 mg)
Number of subjects: 52
Study: 8005815

Group type: EXPERIMENTAL
Intervention: Estramustine phosphate (EMP) plus Velban with concomitant radiotherapy (RT)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Radiotherapy (RT) alone
Number of subjects: 27
Study: 2586565

Group type: COMPARATOR
Intervention: Intensive medical treatment
Number of subjects: 299

Group type: EXPERIMENTAL
Intervention: Peritoneovenous (LeVeen) shunting
Number of subjects: 299
Study: 10953

Group type: EXPERIMENTAL
Intervention: Intravenous labetalol at a dose of 1 mg/kg
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Intravenous labetalol at a dose of 2 mg/kg
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Intravenous labetalol at a dose of 1 mg/kg and 2 mg/kg
Number of subjects: 15
Study: 31811662

Group type: EXPERIMENTAL
Intervention: Inhaled Technosphere Insulin
Number of subjects: 375

Group type: COMPARATOR
Intervention: Subcutaneous insulin aspart
Number of subjects: 375
Study: 30947511

Group type: EXPERIMENTAL
Intervention: ECGI (CardioInsight)
Number of subjects: 8

Group type: COMPARATOR
Intervention: CARTO (Biosense‐Webster, CA)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: ECGI and CARTO comparison
Number of subjects: 8
Study: 28395180

Group type: EXPERIMENTAL
Intervention: Raltegravir-based regimen (RASTA group)
Number of subjects: 58

Group type: COMPARATOR
Intervention: PI or NNRTI based-regimen (controls)
Number of subjects: 58
Study: 25563351

Group type: EXPERIMENTAL
Intervention: Intervention group (educational training, structured process change, review methods, patient education)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 12
Study: 23107581

Group type: EXPERIMENTAL
Intervention: DSAEK
Number of subjects: 173

Group type: COMPARATOR
Intervention: PKP
Number of subjects: 173
Study: 22198600

Group type: EXPERIMENTAL
Intervention: Maximum flexed position compared to standing position
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Seated position compared to standing position
Number of subjects: 5
Study: 18840027

Group type: EXPERIMENTAL
Intervention: Venlafaxine 37.5 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Venlafaxine 75 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 16839780

Group type: EXPERIMENTAL
Intervention: Cortisol (30 mg)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study: 12574793

Group type: EXPERIMENTAL
Intervention: Delapril 30 mg + Indapamide 1.25 mg (D+I)
Number of subjects: 790

Group type: COMPARATOR
Intervention: Captopril 50 mg + Hydrochlorothiazide 15 mg (C+H)
Number of subjects: 790
Study: 10990236

Group type: EXPERIMENTAL
Intervention: Progressive home based knee exercise program
Number of subjects: 179

Group type: COMPARATOR
Intervention: Control program (sham exercise)
Number of subjects: 179
Study: 9358722

Group type: EXPERIMENTAL
Intervention: Barium contrast studies
Number of subjects: 64

Group type: COMPARATOR
Intervention: Plain abdominal X-rays
Number of subjects: 64
Study: 1545660

Group type: EXPERIMENTAL
Intervention: CAAD (diphenhydramine hydrochloride, 50 mg; pseudoephedrine hydrochloride, 60 mg; acetaminophen, 1 g in 10% ethanol)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Diphenhydramine (single dose)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: CAAD
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Diphenhydramine
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 3872241

Group type: EXPERIMENTAL
Intervention: Endoscopic Nd:YAG laser therapy
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sham endoscopy and standard medical therapy (Control)
Number of subjects: 20
Study: 29135832

Group type: EXPERIMENTAL
Intervention: Rituximab
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 27520400

Group type: EXPERIMENTAL
Intervention: Resveratrol 40mg/day (Resv40arm)
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Resveratrol 500mg/day (Resv500arm)
Number of subjects: 192

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 192
Study: 24100705

Group type: EXPERIMENTAL
Intervention: Conservative treatment for back pain and VCF
Number of subjects: 82

Group type: COMPARATOR
Intervention: Insufficient pain relief group
Number of subjects: 82

Group type: COMPARATOR
Intervention: Physiotherapy
Number of subjects: 82
Study: 22425507

Group type: EXPERIMENTAL
Intervention: Risedronate, 35 mg once weekly
Number of subjects: 86

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Risedronate
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Risedronate and Placebo
Number of subjects: 86
Study: 20868284

Group type: EXPERIMENTAL
Intervention: Cell culture-derived influenza vaccine (CCIV)
Number of subjects: 11404

Group type: EXPERIMENTAL
Intervention: Egg-derived trivalent inactivated vaccine (TIV)
Number of subjects: 11404

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11404
Study: 19024795

Group type: EXPERIMENTAL
Intervention: Glabridin (60 mg)
Number of subjects: 0
Study: 15737670

Group type: EXPERIMENTAL
Intervention: Phenytoin (300 mg/day)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 12745493

Group type: EXPERIMENTAL
Intervention: Contingent payment based on breath carbon monoxide levels (CO <= 8 ppm)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Contingent payment with differing amounts based on breath carbon monoxide levels
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group with noncontingent payment
Number of subjects: 0
Study: 12879120

Group type: EXPERIMENTAL
Intervention: Moxifloxacin
Number of subjects: 3

Group type: COMPARATOR
Intervention: Standard antibiotic therapies
Number of subjects: 3
Study: 8973995

Group type: EXPERIMENTAL
Intervention: Lansoprazole (30 mg) with prednisone (40 mg)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Omeprazole (40 mg) with prednisone (40 mg)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo with prednisone (40 mg)
Number of subjects: 18
Study: 1283847

Group type: EXPERIMENTAL
Intervention: Endocrine therapy (single-agent tamoxifen)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chemotherapy combined with endocrine therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Higher doses of chemotherapy with colony-stimulating factors and bone marrow transplantation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combined endocrine therapy
Number of subjects: 0
Study: 3931537

Group type: EXPERIMENTAL
Intervention: Insulin + glibenclamide 5 mg twice daily
Number of subjects: 9

Group type: COMPARATOR
Intervention: Insulin + placebo
Number of subjects: 9
Study: 30646879

Group type: EXPERIMENTAL
Intervention: Group schema-focused therapy enriched with psychomotor therapy (SFT + PMT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 0
Study: 28597302

Group type: EXPERIMENTAL
Intervention: High blood pressure at admission
Number of subjects: 2468

Group type: EXPERIMENTAL
Intervention: Increase in blood pressure after extubation
Number of subjects: 2468

Group type: EXPERIMENTAL
Intervention: Post-operative drainage
Number of subjects: 2468

Group type: COMPARATOR
Intervention: Pre-operative hypertension treatment
Number of subjects: 2468
Study: 26600039

Group type: COMPARATOR
Intervention: Ventral shell spring-hinged AFO (vAFO) - rigid setting
Number of subjects: 15

Group type: COMPARATOR
Intervention: Ventral shell spring-hinged AFO (vAFO) - spring-like setting
Number of subjects: 15

Group type: COMPARATOR
Intervention: All vAFOs
Number of subjects: 15
Study: 23644914

Group type: EXPERIMENTAL
Intervention: Nicotine patch applied to smokers during nicotine withdrawal
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nicotine patch applied to smokers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nicotine patch applied to non-smokers
Number of subjects: 0

Group type: COMPARATOR
Intervention: Smokers during nicotine withdrawal
Number of subjects: 0
Study: 22333098

Group type: EXPERIMENTAL
Intervention: Marvelon (30 µg ethinylestradiol and 150 µg desogestrel) for 21 days
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Progynova 2 mg/d for 21 days and depogesterone 10 mg/d for last 5 days
Number of subjects: 188

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Marvelon and Progynova/Depogesterone
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 188
Study: 19350266

Group type: EXPERIMENTAL
Intervention: Verapamil
Number of subjects: 86

Group type: COMPARATOR
Intervention: Control
Number of subjects: 86
Study: 16458092

Group type: EXPERIMENTAL
Intervention: Latanoprost 0.005%
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Travoprost 0.004%
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Bimatoprost 0.03%
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control (baseline)
Number of subjects: 44